S&P Futures
5,875.25 -21.00 (-0.36%) Dow Futures
43,052.00 -125.00 (-0.29%) Nasdaq Futures
20,437.00 -82.50 (-0.40%) Russell 2000 Futures
2,245.50 -10.00 (-0.44%) Crude Oil
71.15 +0.59 (+0.84%) Gold
2,749.60 +10.70 (+0.39%)
Pre-Market:
| Previous Close | 57.48 |
| Open | 56.18 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 55.87 - 57.48 |
| 52 Week Range | 7.60 - 59.23 |
| Volume | |
| Avg. Volume | 585,803 |
| Market Cap | 2.002B |
| Beta (5Y Monthly) | 0.75 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
3 US Growth Stocks With High Insider Ownership And 167% Earnings Growth
As the U.S. stock market continues to reach new heights, with the Dow Jones Industrial Average marking its 39th record close of the year, investors are increasingly focused on growth opportunities amid strong economic indicators. In this robust environment, stocks with high insider ownership and significant earnings growth can offer compelling prospects for those looking to align their interests with company insiders who have a vested interest in long-term success.
- Insider Monkey
Harrow, Inc. (HROW): A Bull Case Theory
We came across a bullish thesis on Harrow, Inc. (HROW) on Simon’s Substack by Simon. In this article, we will summarize the bulls’ thesis on HROW. HROW Technologies, Inc.’s share was trading at $44.07 as of Sept 27th. HROW’s trailing P/E was 9.64 according to Yahoo Finance. Harrow (NASDAQ: HROW) is a U.S. pharmaceutical company that develops, […]
